Scientists report that canagliflozin, used at clinically relevant concentrations, counteracts lipopolysaccharide-induced vascular hyperpermeability and albumin leakage in wild-type, but not in endothelial-specific α1AMPK-knockout mice.
[Scientific Reports]
6445218
{6445218:WUD268L3}
apa
50
1
164114
https://www.stemcellsciencenews.com/wp-content/plugins/zotpress/